Title: Use of tumor size decrease at 6 weeks (w) to predict response (OR), time to progression (TTP), and survival (OS) in chemorefractory metastatic colorectal cancer (cmCRC) treated with cetuximab (CTX) (BOND trial)
Authors: Piessevaux, H
De Roock, Wendy
Van Cutsem, Eric
Tejpar, Sabine #
Issue Date: 2008
Publisher: Grune & Stratton
Host Document: Journal of Clinical Oncology vol:26 issue:15 pages:4068-4068
Conference: -
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Molecular Digestive Oncology (+)
Clinical Digestive Oncology (+)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.